Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Коагулопатия при кардиохирургических вмешательствах в контексте пандемии COVID-19: мнение о проблеме
Коагулопатия при кардиохирургических вмешательствах в контексте пандемии COVID-19: мнение о проблеме
Басанец А.В., Рахимов А.З., Ибрагимов Р.М., Асымбекова Э.У., Тугеева Э.Ф., Бузиашвили Ю.И. Коагулопатия при кардиохирургических вмешательствах в контексте пандемии COVID-19: мнение о проблеме. Consilium Medicum. 2023;25(1):58–62. DOI: 10.26442/20751753.2023.1.202175
© ООО «КОНСИЛИУМ МЕДИКУМ», 2023 г.
DOI: 10.26442/20751753.2023.1.202175
© ООО «КОНСИЛИУМ МЕДИКУМ», 2023 г.
________________________________________________
DOI: 10.26442/20751753.2023.1.202175
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Пациенты с сопутствующими сердечно-сосудистыми заболеваниями и традиционными кардиоваскулярными факторами риска (возраст, мужской пол, артериальная гипертензия, сахарный диабет и ожирение) относятся к особо уязвимой когорте, отличающейся прогрессирующим тяжелым течением COVID-19 и высокой госпитальной летальностью. Тщательные стратегии скрининга, стандартные рекомендации и протоколы на уровне центров необходимы для выявления пациентов, которые подвергаются большему риску послеоперационных осложнений и летальности. В связи с высокой актуальностью проблемы мы рассматриваем возможное влияние COVID-19 на проходимость шунтированных сосудов коронарных артерий, в основном применительно к венозным шунтам. Однако данная гипотеза нуждается в подтверждении и дальнейшем изучении в рамках клинических рандомизированных исследований.
Ключевые слова: коагулопатия, COVID-19, D-димер
Keywords: coagulopathy, COVID-19, D-dimer
Ключевые слова: коагулопатия, COVID-19, D-димер
________________________________________________
Keywords: coagulopathy, COVID-19, D-dimer
Полный текст
Список литературы
1. Iba T, Levy JH, Connors JM. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020;24(1):360. DOI:10.1186/s13054-020-03077-0
2. Самородов А.В., Золотухин К.Н. Профилактика COVID-19-ассоциированного нарушения гемостаза у пациента со стентированными коронарными артериями. Клинический случай. Креативная хирургия и онкология. 2020;10(2):137-42 [Samorodov AV, Zolotukhin KN. Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical Case. Creative Surgery and Oncology. 2020;10(2):137-42 (in Russian)]. DOI:10.24060/2076-3093-2020-10-2-137-142
3. Doglietto F, Vezzoli M, Gheza F. Factors Associated with Surgical Mortality and Complications Among Patients with and Without Coronavirus Disease 2019 (COVID-19) in Italy. JAMA Surg. 2020;155(8):1-14. DOI:10.1001/jamasurg.2020.2713
4. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14(3):247-50. DOI:10.1016/j.dsx.2020.03.013
5. Mehra M, Desai S, Kuy S, et al. Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020;382(26):2582. DOI:10.1056/NEJMc2021225
6. Gavriilaki E, Anyfanti P, Gavriilaki M, et al. Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses. Curr Hypertens Rep. 2020;22(9):63.
DOI:10.1007/s11906-020-01078-6
7. Siddiqi H, Libby P, Ridker P. COVID-19 – A vascular disease. Trends Cardiovasc Med. 2021;31(1):1-5. DOI:10.1016/j.tcm.2020.10.005
8. Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24(1):353.
DOI:10.1186/s13054-020-03062-7
9. Pourafkari L, Mirza-Aghzadeh-Attari M, Zarrintan A, Mousavi-Aghdas SA. Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study. Iran J Med Sci. 2021;46(1):1-14. DOI:10.30476/ijms.2020.87233.1730
10. Ahmed S, Zimba O, Gasparyan A. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020;39(9):2529-43. DOI:10.1007/s10067-020-05275-1
11. Kashi M, Jacquin A, Dakhil B. Severe arterial thrombosis associated with Covid-19 infection. Thromb Res. 2020;192:75-7. DOI:10.1016/j.thromres.2020.05.025
12. Maiuolo J, Mollace R, Gliozzi M. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-CoV-2 Infection. Int J Mol Sci. 2020;21(23):9309. DOI:10.3390/ijms21239309
13. Colling M, Kanthi Y. COVID-19-associated coagulopathy: An exploration of mechanisms. Vasc Med. 2020;25(5):471-8. DOI:10.1177/1358863X20932640
14. Zhang Y, Xiao M, Zhang S. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020;382(17):e38. DOI:10.1056/NEJMc2007575
15. Lax S, Skok K, Zechner P. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results from a Prospective, Single-Center, Clinicopathologic Case Series. Ann Intern Med. 2020;173(5):350-61. DOI:10.7326/M20-2566
16. Nopp S, Moik F, Jilma B, et al. Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis. Res Pract Thromb Haemost. 2020;4(7):1178-91. DOI:10.1002/rth2.12439
17. Wichmann D, Sperhake J, Lütgehetmann M. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020;173(4):268-77. DOI:10.7326/M20-2003
18. Iwasaki M, Saito J, Zhao H, et al. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications. Inflammation. 2021;44(1):13-34. DOI:10.1007/s10753-020-01337-3
19. Huertas A, Montani D, Savale L. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J. 2020;56(1):2001634.
DOI:10.1183/13993003.01634-2020
20. Sollini M, Ciccarelli M, Cecconi M. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]-FDG-PET/CT study. Eur J Nucl Med Mol Imaging. 2020;1-7. DOI:10.1007/s00259-020-05084-3
21. Fulchand S. Covid-19 and cardiovascular disease. BMJ. 2020;369:m1997. DOI:10.1136/bmj.m1997
22. Shah P, Welt F, Mahmud E. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement. JACC Cardiovasc Interv. 2020;13(12):1484-8. DOI:10.1016/j.jcin.2020.04.001
23. Авдеев С.Н., Адамян Л.В., Алексеева Е.И., и др. Профилактика, диагностика и лечение новой коронавирусной инфекции (2019-nCoV): Временные методические рекомендации. М., 2020. Версия 8.2020 [Avdeev SN, Adamian LV, Alekseeva EI, et al. Profilaktika, diagnostika i lecheniie novoi koronavirusnoi infektsii (2019-nCoV): Vremennyie metodicheskiie rekomendatsii. Moscow, 2020. Versiia 8.2020 (in Russian)].
24. Thachil J, Tang N, Gando S. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023-6. DOI:10.1111/jth.14810
25. Topal G, Loesch A, Dashwood M. COVID-19 – Endothelial Axis and Coronary Artery Bypass Graft Patency: A Target for Therapeutic Intervention? Braz J Cardiovasc Surg. 2020;35(5):757-63. DOI:10.21470/1678-9741-2020-0303
26. Lei S, Jiang F, Su W. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020;21:100331. DOI:10.1016/j.eclinm.2020.100331
27. Jin Y, Ji W, Yang H, et al. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct Target Ther. 2020;5(1):293. DOI:10.1038/s41392-020-00454-7
28. Liu Z, Li J, Chen D. Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19. Front Pharmacol. 2020;11:1093. DOI:10.3389/fphar.2020.01093
29. Gando S, Fujishima S, Saitoh D. The significance of disseminated intravascular coagulation on multiple organ dysfunction during the early stage of acute respiratory distress syndrome. Thromb Res. 2020;191:15-21. DOI:10.1016/j.thromres.2020.03.023
30. Li J, Liu Z, Wu G. D-Dimer as a Prognostic Indicator in Critically Ill Patients Hospitalized With COVID-19 in Leishenshan Hospital, Wuhan, China. Front Pharmacol. 2020;11:600592. DOI:10.3389/fphar.2020.600592
31. Biswas S, Thakur V, Kaur P, et al. Blood clots in COVID-19 patients: Simplifying the curious mystery. Med Hypotheses. 2021;146:110371. DOI:10.1016/j.mehy.2020.110371
32. Chen J, Wang X, Zhang S. Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan. Clin Appl Thromb Hemost. 2020;26:1076029620936772. DOI:10.1177/1076029620936772
33. Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094-9. DOI:10.1111/jth.14817
34. Hayıroğlu M, Çınar T, Tekkeşin A. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review. Rev Assoc Med Bras. 2020;66(6):842-8. DOI:10.1590/1806-9282.66.6.842
35. Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. DOI:10.1016/S0140-6736(20)30566-3
36. Ingraham N, Barakat A, Reilkoff R. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur Respir J. 2020;56(1):2000912. DOI:10.1183/13993003.00912-2020
37. Varga Z, Flammer A, Steiger P. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8. DOI:10.1016/S0140-6736(20)30937-5
2. Самородов А.В., Золотухин К.Н. Профилактика COVID-19-ассоциированного нарушения гемостаза у пациента со стентированными коронарными артериями. Клинический случай. Креативная хирургия и онкология. 2020;10(2):137-42 [Samorodov AV, Zolotukhin KN. Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical Case. Creative Surgery and Oncology. 2020;10(2):137-42 (in Russian)]. DOI:10.24060/2076-3093-2020-10-2-137-142
3. Doglietto F, Vezzoli M, Gheza F. Factors Associated with Surgical Mortality and Complications Among Patients with and Without Coronavirus Disease 2019 (COVID-19) in Italy. JAMA Surg. 2020;155(8):1-14. DOI:10.1001/jamasurg.2020.2713
4. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14(3):247-50. DOI:10.1016/j.dsx.2020.03.013
5. Mehra M, Desai S, Kuy S, et al. Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020;382(26):2582. DOI:10.1056/NEJMc2021225
6. Gavriilaki E, Anyfanti P, Gavriilaki M, et al. Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses. Curr Hypertens Rep. 2020;22(9):63.
DOI:10.1007/s11906-020-01078-6
7. Siddiqi H, Libby P, Ridker P. COVID-19 – A vascular disease. Trends Cardiovasc Med. 2021;31(1):1-5. DOI:10.1016/j.tcm.2020.10.005
8. Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24(1):353.
DOI:10.1186/s13054-020-03062-7
9. Pourafkari L, Mirza-Aghzadeh-Attari M, Zarrintan A, Mousavi-Aghdas SA. Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study. Iran J Med Sci. 2021;46(1):1-14. DOI:10.30476/ijms.2020.87233.1730
10. Ahmed S, Zimba O, Gasparyan A. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020;39(9):2529-43. DOI:10.1007/s10067-020-05275-1
11. Kashi M, Jacquin A, Dakhil B. Severe arterial thrombosis associated with Covid-19 infection. Thromb Res. 2020;192:75-7. DOI:10.1016/j.thromres.2020.05.025
12. Maiuolo J, Mollace R, Gliozzi M. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-CoV-2 Infection. Int J Mol Sci. 2020;21(23):9309. DOI:10.3390/ijms21239309
13. Colling M, Kanthi Y. COVID-19-associated coagulopathy: An exploration of mechanisms. Vasc Med. 2020;25(5):471-8. DOI:10.1177/1358863X20932640
14. Zhang Y, Xiao M, Zhang S. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020;382(17):e38. DOI:10.1056/NEJMc2007575
15. Lax S, Skok K, Zechner P. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results from a Prospective, Single-Center, Clinicopathologic Case Series. Ann Intern Med. 2020;173(5):350-61. DOI:10.7326/M20-2566
16. Nopp S, Moik F, Jilma B, et al. Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis. Res Pract Thromb Haemost. 2020;4(7):1178-91. DOI:10.1002/rth2.12439
17. Wichmann D, Sperhake J, Lütgehetmann M. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020;173(4):268-77. DOI:10.7326/M20-2003
18. Iwasaki M, Saito J, Zhao H, et al. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications. Inflammation. 2021;44(1):13-34. DOI:10.1007/s10753-020-01337-3
19. Huertas A, Montani D, Savale L. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J. 2020;56(1):2001634.
DOI:10.1183/13993003.01634-2020
20. Sollini M, Ciccarelli M, Cecconi M. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]-FDG-PET/CT study. Eur J Nucl Med Mol Imaging. 2020;1-7. DOI:10.1007/s00259-020-05084-3
21. Fulchand S. Covid-19 and cardiovascular disease. BMJ. 2020;369:m1997. DOI:10.1136/bmj.m1997
22. Shah P, Welt F, Mahmud E. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement. JACC Cardiovasc Interv. 2020;13(12):1484-8. DOI:10.1016/j.jcin.2020.04.001
23. Avdeev SN, Adamian LV, Alekseeva EI, et al. Profilaktika, diagnostika i lecheniie novoi koronavirusnoi infektsii (2019-nCoV): Vremennyie metodicheskiie rekomendatsii. Moscow, 2020. Versiia 8.2020 (in Russian).
24. Thachil J, Tang N, Gando S. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023-6. DOI:10.1111/jth.14810
25. Topal G, Loesch A, Dashwood M. COVID-19 – Endothelial Axis and Coronary Artery Bypass Graft Patency: A Target for Therapeutic Intervention? Braz J Cardiovasc Surg. 2020;35(5):757-63. DOI:10.21470/1678-9741-2020-0303
26. Lei S, Jiang F, Su W. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020;21:100331. DOI:10.1016/j.eclinm.2020.100331
27. Jin Y, Ji W, Yang H, et al. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct Target Ther. 2020;5(1):293. DOI:10.1038/s41392-020-00454-7
28. Liu Z, Li J, Chen D. Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19. Front Pharmacol. 2020;11:1093. DOI:10.3389/fphar.2020.01093
29. Gando S, Fujishima S, Saitoh D. The significance of disseminated intravascular coagulation on multiple organ dysfunction during the early stage of acute respiratory distress syndrome. Thromb Res. 2020;191:15-21. DOI:10.1016/j.thromres.2020.03.023
30. Li J, Liu Z, Wu G. D-Dimer as a Prognostic Indicator in Critically Ill Patients Hospitalized With COVID-19 in Leishenshan Hospital, Wuhan, China. Front Pharmacol. 2020;11:600592. DOI:10.3389/fphar.2020.600592
31. Biswas S, Thakur V, Kaur P, et al. Blood clots in COVID-19 patients: Simplifying the curious mystery. Med Hypotheses. 2021;146:110371. DOI:10.1016/j.mehy.2020.110371
32. Chen J, Wang X, Zhang S. Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan. Clin Appl Thromb Hemost. 2020;26:1076029620936772. DOI:10.1177/1076029620936772
33. Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094-9. DOI:10.1111/jth.14817
34. Hayıroğlu M, Çınar T, Tekkeşin A. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review. Rev Assoc Med Bras. 2020;66(6):842-8. DOI:10.1590/1806-9282.66.6.842
35. Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. DOI:10.1016/S0140-6736(20)30566-3
36. Ingraham N, Barakat A, Reilkoff R. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur Respir J. 2020;56(1):2000912. DOI:10.1183/13993003.00912-2020
37. Varga Z, Flammer A, Steiger P. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8. DOI:10.1016/S0140-6736(20)30937-5
2. Самородов А.В., Золотухин К.Н. Профилактика COVID-19-ассоциированного нарушения гемостаза у пациента со стентированными коронарными артериями. Клинический случай. Креативная хирургия и онкология. 2020;10(2):137-42 [Samorodov AV, Zolotukhin KN. Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical Case. Creative Surgery and Oncology. 2020;10(2):137-42 (in Russian)]. DOI:10.24060/2076-3093-2020-10-2-137-142
3. Doglietto F, Vezzoli M, Gheza F. Factors Associated with Surgical Mortality and Complications Among Patients with and Without Coronavirus Disease 2019 (COVID-19) in Italy. JAMA Surg. 2020;155(8):1-14. DOI:10.1001/jamasurg.2020.2713
4. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14(3):247-50. DOI:10.1016/j.dsx.2020.03.013
5. Mehra M, Desai S, Kuy S, et al. Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020;382(26):2582. DOI:10.1056/NEJMc2021225
6. Gavriilaki E, Anyfanti P, Gavriilaki M, et al. Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses. Curr Hypertens Rep. 2020;22(9):63.
DOI:10.1007/s11906-020-01078-6
7. Siddiqi H, Libby P, Ridker P. COVID-19 – A vascular disease. Trends Cardiovasc Med. 2021;31(1):1-5. DOI:10.1016/j.tcm.2020.10.005
8. Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24(1):353.
DOI:10.1186/s13054-020-03062-7
9. Pourafkari L, Mirza-Aghzadeh-Attari M, Zarrintan A, Mousavi-Aghdas SA. Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study. Iran J Med Sci. 2021;46(1):1-14. DOI:10.30476/ijms.2020.87233.1730
10. Ahmed S, Zimba O, Gasparyan A. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020;39(9):2529-43. DOI:10.1007/s10067-020-05275-1
11. Kashi M, Jacquin A, Dakhil B. Severe arterial thrombosis associated with Covid-19 infection. Thromb Res. 2020;192:75-7. DOI:10.1016/j.thromres.2020.05.025
12. Maiuolo J, Mollace R, Gliozzi M. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-CoV-2 Infection. Int J Mol Sci. 2020;21(23):9309. DOI:10.3390/ijms21239309
13. Colling M, Kanthi Y. COVID-19-associated coagulopathy: An exploration of mechanisms. Vasc Med. 2020;25(5):471-8. DOI:10.1177/1358863X20932640
14. Zhang Y, Xiao M, Zhang S. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020;382(17):e38. DOI:10.1056/NEJMc2007575
15. Lax S, Skok K, Zechner P. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results from a Prospective, Single-Center, Clinicopathologic Case Series. Ann Intern Med. 2020;173(5):350-61. DOI:10.7326/M20-2566
16. Nopp S, Moik F, Jilma B, et al. Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis. Res Pract Thromb Haemost. 2020;4(7):1178-91. DOI:10.1002/rth2.12439
17. Wichmann D, Sperhake J, Lütgehetmann M. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020;173(4):268-77. DOI:10.7326/M20-2003
18. Iwasaki M, Saito J, Zhao H, et al. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications. Inflammation. 2021;44(1):13-34. DOI:10.1007/s10753-020-01337-3
19. Huertas A, Montani D, Savale L. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J. 2020;56(1):2001634.
DOI:10.1183/13993003.01634-2020
20. Sollini M, Ciccarelli M, Cecconi M. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]-FDG-PET/CT study. Eur J Nucl Med Mol Imaging. 2020;1-7. DOI:10.1007/s00259-020-05084-3
21. Fulchand S. Covid-19 and cardiovascular disease. BMJ. 2020;369:m1997. DOI:10.1136/bmj.m1997
22. Shah P, Welt F, Mahmud E. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement. JACC Cardiovasc Interv. 2020;13(12):1484-8. DOI:10.1016/j.jcin.2020.04.001
23. Авдеев С.Н., Адамян Л.В., Алексеева Е.И., и др. Профилактика, диагностика и лечение новой коронавирусной инфекции (2019-nCoV): Временные методические рекомендации. М., 2020. Версия 8.2020 [Avdeev SN, Adamian LV, Alekseeva EI, et al. Profilaktika, diagnostika i lecheniie novoi koronavirusnoi infektsii (2019-nCoV): Vremennyie metodicheskiie rekomendatsii. Moscow, 2020. Versiia 8.2020 (in Russian)].
24. Thachil J, Tang N, Gando S. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023-6. DOI:10.1111/jth.14810
25. Topal G, Loesch A, Dashwood M. COVID-19 – Endothelial Axis and Coronary Artery Bypass Graft Patency: A Target for Therapeutic Intervention? Braz J Cardiovasc Surg. 2020;35(5):757-63. DOI:10.21470/1678-9741-2020-0303
26. Lei S, Jiang F, Su W. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020;21:100331. DOI:10.1016/j.eclinm.2020.100331
27. Jin Y, Ji W, Yang H, et al. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct Target Ther. 2020;5(1):293. DOI:10.1038/s41392-020-00454-7
28. Liu Z, Li J, Chen D. Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19. Front Pharmacol. 2020;11:1093. DOI:10.3389/fphar.2020.01093
29. Gando S, Fujishima S, Saitoh D. The significance of disseminated intravascular coagulation on multiple organ dysfunction during the early stage of acute respiratory distress syndrome. Thromb Res. 2020;191:15-21. DOI:10.1016/j.thromres.2020.03.023
30. Li J, Liu Z, Wu G. D-Dimer as a Prognostic Indicator in Critically Ill Patients Hospitalized With COVID-19 in Leishenshan Hospital, Wuhan, China. Front Pharmacol. 2020;11:600592. DOI:10.3389/fphar.2020.600592
31. Biswas S, Thakur V, Kaur P, et al. Blood clots in COVID-19 patients: Simplifying the curious mystery. Med Hypotheses. 2021;146:110371. DOI:10.1016/j.mehy.2020.110371
32. Chen J, Wang X, Zhang S. Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan. Clin Appl Thromb Hemost. 2020;26:1076029620936772. DOI:10.1177/1076029620936772
33. Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094-9. DOI:10.1111/jth.14817
34. Hayıroğlu M, Çınar T, Tekkeşin A. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review. Rev Assoc Med Bras. 2020;66(6):842-8. DOI:10.1590/1806-9282.66.6.842
35. Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. DOI:10.1016/S0140-6736(20)30566-3
36. Ingraham N, Barakat A, Reilkoff R. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur Respir J. 2020;56(1):2000912. DOI:10.1183/13993003.00912-2020
37. Varga Z, Flammer A, Steiger P. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8. DOI:10.1016/S0140-6736(20)30937-5
________________________________________________
2. Самородов А.В., Золотухин К.Н. Профилактика COVID-19-ассоциированного нарушения гемостаза у пациента со стентированными коронарными артериями. Клинический случай. Креативная хирургия и онкология. 2020;10(2):137-42 [Samorodov AV, Zolotukhin KN. Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical Case. Creative Surgery and Oncology. 2020;10(2):137-42 (in Russian)]. DOI:10.24060/2076-3093-2020-10-2-137-142
3. Doglietto F, Vezzoli M, Gheza F. Factors Associated with Surgical Mortality and Complications Among Patients with and Without Coronavirus Disease 2019 (COVID-19) in Italy. JAMA Surg. 2020;155(8):1-14. DOI:10.1001/jamasurg.2020.2713
4. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14(3):247-50. DOI:10.1016/j.dsx.2020.03.013
5. Mehra M, Desai S, Kuy S, et al. Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020;382(26):2582. DOI:10.1056/NEJMc2021225
6. Gavriilaki E, Anyfanti P, Gavriilaki M, et al. Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses. Curr Hypertens Rep. 2020;22(9):63.
DOI:10.1007/s11906-020-01078-6
7. Siddiqi H, Libby P, Ridker P. COVID-19 – A vascular disease. Trends Cardiovasc Med. 2021;31(1):1-5. DOI:10.1016/j.tcm.2020.10.005
8. Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24(1):353.
DOI:10.1186/s13054-020-03062-7
9. Pourafkari L, Mirza-Aghzadeh-Attari M, Zarrintan A, Mousavi-Aghdas SA. Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study. Iran J Med Sci. 2021;46(1):1-14. DOI:10.30476/ijms.2020.87233.1730
10. Ahmed S, Zimba O, Gasparyan A. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020;39(9):2529-43. DOI:10.1007/s10067-020-05275-1
11. Kashi M, Jacquin A, Dakhil B. Severe arterial thrombosis associated with Covid-19 infection. Thromb Res. 2020;192:75-7. DOI:10.1016/j.thromres.2020.05.025
12. Maiuolo J, Mollace R, Gliozzi M. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-CoV-2 Infection. Int J Mol Sci. 2020;21(23):9309. DOI:10.3390/ijms21239309
13. Colling M, Kanthi Y. COVID-19-associated coagulopathy: An exploration of mechanisms. Vasc Med. 2020;25(5):471-8. DOI:10.1177/1358863X20932640
14. Zhang Y, Xiao M, Zhang S. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020;382(17):e38. DOI:10.1056/NEJMc2007575
15. Lax S, Skok K, Zechner P. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results from a Prospective, Single-Center, Clinicopathologic Case Series. Ann Intern Med. 2020;173(5):350-61. DOI:10.7326/M20-2566
16. Nopp S, Moik F, Jilma B, et al. Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis. Res Pract Thromb Haemost. 2020;4(7):1178-91. DOI:10.1002/rth2.12439
17. Wichmann D, Sperhake J, Lütgehetmann M. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020;173(4):268-77. DOI:10.7326/M20-2003
18. Iwasaki M, Saito J, Zhao H, et al. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications. Inflammation. 2021;44(1):13-34. DOI:10.1007/s10753-020-01337-3
19. Huertas A, Montani D, Savale L. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J. 2020;56(1):2001634.
DOI:10.1183/13993003.01634-2020
20. Sollini M, Ciccarelli M, Cecconi M. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]-FDG-PET/CT study. Eur J Nucl Med Mol Imaging. 2020;1-7. DOI:10.1007/s00259-020-05084-3
21. Fulchand S. Covid-19 and cardiovascular disease. BMJ. 2020;369:m1997. DOI:10.1136/bmj.m1997
22. Shah P, Welt F, Mahmud E. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement. JACC Cardiovasc Interv. 2020;13(12):1484-8. DOI:10.1016/j.jcin.2020.04.001
23. Avdeev SN, Adamian LV, Alekseeva EI, et al. Profilaktika, diagnostika i lecheniie novoi koronavirusnoi infektsii (2019-nCoV): Vremennyie metodicheskiie rekomendatsii. Moscow, 2020. Versiia 8.2020 (in Russian).
24. Thachil J, Tang N, Gando S. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023-6. DOI:10.1111/jth.14810
25. Topal G, Loesch A, Dashwood M. COVID-19 – Endothelial Axis and Coronary Artery Bypass Graft Patency: A Target for Therapeutic Intervention? Braz J Cardiovasc Surg. 2020;35(5):757-63. DOI:10.21470/1678-9741-2020-0303
26. Lei S, Jiang F, Su W. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020;21:100331. DOI:10.1016/j.eclinm.2020.100331
27. Jin Y, Ji W, Yang H, et al. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct Target Ther. 2020;5(1):293. DOI:10.1038/s41392-020-00454-7
28. Liu Z, Li J, Chen D. Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19. Front Pharmacol. 2020;11:1093. DOI:10.3389/fphar.2020.01093
29. Gando S, Fujishima S, Saitoh D. The significance of disseminated intravascular coagulation on multiple organ dysfunction during the early stage of acute respiratory distress syndrome. Thromb Res. 2020;191:15-21. DOI:10.1016/j.thromres.2020.03.023
30. Li J, Liu Z, Wu G. D-Dimer as a Prognostic Indicator in Critically Ill Patients Hospitalized With COVID-19 in Leishenshan Hospital, Wuhan, China. Front Pharmacol. 2020;11:600592. DOI:10.3389/fphar.2020.600592
31. Biswas S, Thakur V, Kaur P, et al. Blood clots in COVID-19 patients: Simplifying the curious mystery. Med Hypotheses. 2021;146:110371. DOI:10.1016/j.mehy.2020.110371
32. Chen J, Wang X, Zhang S. Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan. Clin Appl Thromb Hemost. 2020;26:1076029620936772. DOI:10.1177/1076029620936772
33. Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094-9. DOI:10.1111/jth.14817
34. Hayıroğlu M, Çınar T, Tekkeşin A. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review. Rev Assoc Med Bras. 2020;66(6):842-8. DOI:10.1590/1806-9282.66.6.842
35. Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. DOI:10.1016/S0140-6736(20)30566-3
36. Ingraham N, Barakat A, Reilkoff R. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur Respir J. 2020;56(1):2000912. DOI:10.1183/13993003.00912-2020
37. Varga Z, Flammer A, Steiger P. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8. DOI:10.1016/S0140-6736(20)30937-5
Авторы
А.В. Басанец*, А.З. Рахимов, Р.М. Ибрагимов, Э.У. Асымбекова, Э.Ф. Тугеева, Ю.И. Бузиашвили
ФГБУ «Национальный медицинский исследовательский центр сердечно-сосудистой хирургии им. А.Н. Бакулева» Минздрава России, Москва, Россия
*anna.basanets1000@gmail.com
Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russia
*anna.basanets1000@gmail.com
ФГБУ «Национальный медицинский исследовательский центр сердечно-сосудистой хирургии им. А.Н. Бакулева» Минздрава России, Москва, Россия
*anna.basanets1000@gmail.com
________________________________________________
Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russia
*anna.basanets1000@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.